Mutations in the FH gene have been identified in various types of tumors, including hereditary leiomyomatosis and renal cell carcinoma (HLRCC), a condition characterized by the development of multiple benign and malignant tumors. Here, FH is linked to hereditary leiomyomatosis and renal cell cancer.